Furthermore, they reported that LINC00665 knockdown increased the cytotoxic activity of gemcitabine on cell apoptosis and growth, thereby weakening gemcitabine tolerance of resistant cholangiocarcinoma cells (Lu et al., 2021). This evidence concerns the gene LINC00665 and cholangiocarcinoma.